Annual Accounts Payable
$25.51 M
+$10.68 M+72.03%
31 December 2023
Summary:
AbCellera Biologics annual accounts payable is currently $25.51 million, with the most recent change of +$10.68 million (+72.03%) on 31 December 2023. During the last 3 years, it has risen by +$18.19 million (+248.48%). ABCL annual accounts payable is now at all-time high.ABCL Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Accounts Payable
$34.80 M
+$8.21 M+30.88%
30 September 2024
Summary:
AbCellera Biologics quarterly accounts payable is currently $34.80 million, with the most recent change of +$8.21 million (+30.88%) on 30 September 2024. Over the past year, it has increased by +$17.36 million (+99.60%). ABCL quarterly accounts payable is now at all-time high.ABCL Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ABCL Accounts Payable Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +72.0% | +99.6% |
| 3 y3 years | +248.5% | +290.6% |
| 5 y5 years | +1580.2% | - |
ABCL Accounts Payable High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +248.5% | at high | +290.6% |
| 5 y | 5 years | at high | +1580.2% | at high | +2016.5% |
| alltime | all time | at high | +1580.2% | at high | +2016.5% |
AbCellera Biologics Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $34.80 M(+30.9%) |
| June 2024 | - | $26.59 M(-1.2%) |
| Mar 2024 | - | $26.91 M(+5.5%) |
| Dec 2023 | $25.51 M(+72.0%) | $25.51 M(+46.3%) |
| Sept 2023 | - | $17.43 M(-17.1%) |
| June 2023 | - | $21.02 M(+19.7%) |
| Mar 2023 | - | $17.57 M(+18.5%) |
| Dec 2022 | $14.83 M | $14.83 M(+59.1%) |
| Sept 2022 | - | $9.32 M(-9.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2022 | - | $10.31 M(-0.4%) |
| Mar 2022 | - | $10.35 M(-30.6%) |
| Dec 2021 | $14.92 M(+103.9%) | $14.92 M(+67.5%) |
| Sept 2021 | - | $8.91 M(+58.9%) |
| June 2021 | - | $5.61 M(+56.3%) |
| Mar 2021 | - | $3.58 M(-51.0%) |
| Dec 2020 | $7.32 M(+345.3%) | $7.32 M(+345.3%) |
| Dec 2019 | $1.64 M(+8.3%) | $1.64 M |
| Dec 2018 | $1.52 M | - |
FAQ
- What is AbCellera Biologics annual accounts payable?
- What is the all time high annual accounts payable for AbCellera Biologics?
- What is AbCellera Biologics annual accounts payable year-on-year change?
- What is AbCellera Biologics quarterly accounts payable?
- What is the all time high quarterly accounts payable for AbCellera Biologics?
- What is AbCellera Biologics quarterly accounts payable year-on-year change?
What is AbCellera Biologics annual accounts payable?
The current annual accounts payable of ABCL is $25.51 M
What is the all time high annual accounts payable for AbCellera Biologics?
AbCellera Biologics all-time high annual accounts payable is $25.51 M
What is AbCellera Biologics annual accounts payable year-on-year change?
Over the past year, ABCL annual accounts payable has changed by +$10.68 M (+72.03%)
What is AbCellera Biologics quarterly accounts payable?
The current quarterly accounts payable of ABCL is $34.80 M
What is the all time high quarterly accounts payable for AbCellera Biologics?
AbCellera Biologics all-time high quarterly accounts payable is $34.80 M
What is AbCellera Biologics quarterly accounts payable year-on-year change?
Over the past year, ABCL quarterly accounts payable has changed by +$17.36 M (+99.60%)